INTRODUCTION
Chitin is a tough, rigid, protective, linear polymer of b(1,4)-N-acetyl-D-glucosamine (GlcNAc) and is a component of arthropod exoskeletons and the cell walls of fungi. In these organisms a dynamic balance between chitin synthesis (through chitin synthases) and chitin hydrolysis (through chitinases) is required to allow for growth and morphogenesis [1] . Chitinases, the enzymes that catalyze the hydrolysis of the b(1,4)-glycosidic bonds between GlcNAc monomers, belong to CAZY (http://afmb.cnrs-mrs.fr/CAZY) [2] glycoside hydrolase family 18 or 19. Fungi belonging to the phylum Ascomycota possess several family 18 chitinases belonging to two subclasses-some of these enzymes are similar to the well-characterized plant chitinase hevamine from Hevea brasiliensis [3] [4] [5] (the ''plant-type'' family 18 chitinases), whereas others are similar to the chitinases first characterized in bacteria (''bacterial-type'' family 18 chitinases) [6] . For instance, Saccharomyces cerevisiae possesses two chitinase-encoding genes: the plant-type chitinase ScCTS1 [7] with an apparent molecular weight of 130 kDa (including glycosylation) showing sequence similarity to hevamine; and ScCTS2 [8] , which is more similar to bacterial chitinases like chitinase A and B from Serratia marcescens [6] . The genomes of the fungal pathogens Aspergillus fumigatus and Candida albicans contain many chitinases, with the former containing 14 chitinases (of which 5 are of the plant-type [9] ) and the latter 4 (of which 3 are of the plant-type [10] ).
The bacterial-type chitinases have been extensively studied. These enzymes are generally believed to show mainly exo-activity, i.e., removing short chitooligosaccharides from the end of long chitin chains [6] . Structures for several of these enzymes, including chitinases A and B from S. marcescens [11, 12] and several fungal chitinases [13, 14] and mammalian chitinases [15] , have been reported, revealing a conserved catalytic core with several exposed aromatic residues that are important for substrate binding ( Figure 1 ). Gene disruption studies of the bacterial-type chitinase genes in A. fumigatus and Coccidioides immitis have not revealed any significant phenotype, and it has been suggested that this subclass of family 18 chitinases plays a role in metabolizing short exogenous chitooligosaccharides [16, 17] . In contrast, observable phenotypes have been reported for the disruption of plant-type chitinases in fungi. A knockout of the cts1 gene in S. cerevisiae resulted in a ''clumping'' phenotype, where, after cell division, mother and daughter cells were unable to separate [18] . Treatment of S. cerevisiae with a derivative of allosamidin (a well-characterized chitinase inhibitor [19] ) gave a remarkably similar phenotype [20] . Furthermore, disruption of the chiA gene in A. nidulans resulted in reduced germination and hyphal growth [21] . Deletion of chitinase 3 from C. albicans generated elongated chains of unseparated cells in the yeast growth phase, resembling the phenotype of S. cerevisiae cts1 knockouts [10] .
Despite the key role these plant-type chitinases appear to play in fungal cell wall morphology and biogenesis, they have not been extensively characterized. ScCTS1 is divided into four domains [18] : a signal sequence (amino acids [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] , a catalytic domain (amino acids 21-315), a Ser/Thr-rich domain (amino acids 315-480), and a high-affinity chitin-binding domain (amino acids 481-562). This domain organization is similar to most of the plant-type chitinases in A. fumigatus and C. albicans [9, 10] . The chitin-binding domain of ScCTS1 may have a role in localizing the enzyme to the cell wall [18] . Perhaps due to their size, domain organization, or membrane localization, only a few plant-type fungal chitinases have so far been successfully overproduced in recombinant form (e.g., [22] ). However, hevamine, the plant chitinase from H. brasiliensis, has been characterized in some detail. Hevamine has been shown to be an endo-chitinase [3, 5] with a catalytic core distantly similar to those of the bacterialtype chitinases, but possessing a more exposed substrate-binding groove. Structural work on hevamine in conjunction with inhibitor studies was instrumental in showing that this enzyme, and indeed all family 18 chitinases, proceed through a ''substrate-assisted'' reaction mechanism where the N-acetyl moiety of the sugar toward the nonreducing end of the glycosidic bond acts as a nucleophile, forming an oxazolinium ion intermediate [3, 23, 24] . The potent chitinase inhibitor allosamidin, a pseudotrisaccharide [19, 25] , accurately mimics this reaction intermediate, as elegantly shown through X-ray crystallographic studies [23] , and inhibits most chitinases from the GH 18 family. Mutagenesis studies on hevamine have confirmed the role of the two acids in the conserved GH 18 DxE motif, with the glutamate being the catalytic acid protonating the glycosidic bond, and the aspartate playing a key role in assisting the acetamido group in its nucleophilic attack and stabilizing the developing positive charge on the oxazolinium ion [5, 24] .
Despite the considerable amount of genetic data on the fungal plant-type chitinases, their precise roles are still unclear. This is largely due to the presence of many of these genes in the fungal genomes and the shortcomings of the genetic approach in terms of generating multiple-gene knockouts to overcome the effects of redundancy. Given the relatively large degree of sequence conservation of these enzymes, it is possible that a potent, specific, small-molecule inhibitor could be developed that would inhibit all plant-type chitinases, allowing the phenotype of a total knockdown of these enzymes to be studied. Furthermore, such a molecule could be a lead for the development of a chitinase inhibitor with antifungal properties.
Here, we have taken a first step in this direction by developing an overexpression system for ScCTS1 and determining its structure by X-ray crystallography. A Native ScCTS1 structure compared to the hevamine-allosamidin (PDB code 1LLO [23] ) and AfChiB-allosamidin (PDB code 2A3E [14] ) complexes. The Glu157 and Asp155 from the family 18 chitinase DxE motif are shown with cyan carbon atoms (the equivalent residues in hevamine and AfChiB are shown with the same colors). The three disulphide bridges in ScCTS1 and hevamine are represented in yellow. Solvent-exposed aromatic residues are shown with green carbon atoms. Allosamidin is shown with magenta carbon atoms.
high-throughput screen based on a fluorescent enzyme assay was then used to identify three inhibitor scaffolds. The most potent of these, kinetin (K i = 3.2 mM), is a competitive inhibitor of the enzyme that occupies a deep pocket. Site-directed mutagenesis was used to reveal the importance of this pocket in determining inhibitor potency. This work provides a solid basis for the development of a plant-type fungal chitinase inhibitor.
RESULTS AND DISCUSSION

ScCTS1
Contains a Substrate-Binding Groove Compatible with Endo Activity Characterization of the activity and structure of the ''planttype'' fungal chitinases has been hampered by difficulties in overexpressing recombinant forms of these enzymes. We have expressed the catalytic domain of ScCTS1 (comprising of amino acids 22 to 315) as a secreted N-terminally His-tagged fusion protein in Pichia pastoris, producing approximately 50 mg per liter of medium. Purification using Ni-affinity chromatography and gel filtration yielded approximately 15 mg of pure protein per liter of media. The protein was then crystallized from phosphate buffers, and the structure was solved by molecular replacement and refined against synchrotron diffraction data to 1.6 Å ( Table 1) .
The ScCTS1 structure represents the first example, to our knowledge, of a plant-type fungal chitinase. The nearest structural homolog is the plant chitinase hevamine [3] , which is 36% identical at the sequence level and superposes onto ScCTS1 with an rmsd of 1.6 Å on 256 Ca atoms ( Figure 1 ). The typical (b/a) 8 TIM-barrel is structurally conserved, as are the three disulphide bonds (Figure 1) .
Although the active site residues and TIM-barrel fold are conserved, there exist significant structural differences between ScCTS1 and the bacterial-type fungal chitinase, as evident from a comparison with the A. fumigatus chitinase B1 (AfChiB1) structure [14] (Figure 1 ). Most notable is the fact that, whereas ScCTS1 and hevamine contain a minimal TIM-barrel fold similar to the structure of TinyTIM [26] , AfChiB1 contains a highly decorated TIMbarrel with a large a/b domain inserted in one of the loops and several other larger loops (Figure 1 ). The result of this is that, whereas ScCTS1 and hevamine contain a shallow substrate-binding groove, the bacterial-type chitinases contain deep substrate-binding grooves, in some cases even forming tunnels [11] [12] [13] [14] [15] 27] . There are further significant differences in the nature of the side chains lining the substrate-binding grooves. Whereas a large path of highly conserved aromatic residues involved in substrate binding lines the active-site grooves of the bacterial-type chitinases [15, 27, 28] , there is only one conserved solventexposed tryptophan in ScCTS1 (Trp285) and hevamine (Trp255) (Figure 1) . This difference in substrate-binding groove architecture correlates with the known endo-chitinase activities of ScCTS1 [7] and hevamine [4] and the mostly exo-acting bacterial-type chitinases [6] . Values in parentheses are for the highest resolution shell. All measured data were included in structure refinement. All crystals were of space group P2 1 2 1 2.
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The Plant-Type Fungal Chitinases Possess a Conserved Active Site Previous structural studies of hevamine in complex with the inhibitor allosamidin [23] (Figures 1 and 2B ) or substrate fragments [3, 24] have defined the GlcNAc subsites in the enzyme, which form a shallow groove on the surface of the protein, also observed in the ScCTS1 structure ( Figure 2B ). The groove consists of six sugar-binding subsites, numbered from À4 (the nonreducing end) to +2 (the reducing end), with hydrolysis taking place on the glycosidic bond between the À1 and +1 subsites [3, 23, 24] . Subsites À4 and À3 are highly solvent exposed, and the side chains forming these subsites are not well conserved (Figures 2A and 2B ). Subsites À2 to +2 form a deep groove, lined by side chains that are highly conserved in the plant-type family 18 chitinases (Figures 2A and 2B ). In the À1 subsite, Asp155 and Glu157 in ScCTS1 (equivalent to Asp125 and Glu127 in hevamine) at the end of b4 correspond to the residues in the family 18 chitinase DxE motif (see CAZY [2] ). Glu157 is the catalytic acid, with Asp155 stabilizing the oxazolinium ring of the reaction intermediate. Notably, a tryptophan that is completely conserved in all family 18 chitinases (Trp285 in ScCTS1, equivalent to Trp255 in hevamine) forms the bottom of the À1 subsite, with a conserved tyrosine (Tyr214 in ScCTS1, equivalent to Tyr183 in hevamine) forming one of the sides. The À2 and À3 subsites are considerably more exposed; nevertheless, most of the residues that are seen to hydrogen bond the À2/À3 sugars in the hevamine-allosamidin complex are also conserved in ScCTS1 [23] ( Figure 2B ). In the ScCTS1 structure, a pocket lined with conserved residues is observed next to the À1 subsite (Figures 2A and 2B ).
Recombinant ScCTS1 Is Active against 4MU-Glycosides
The activities of ScCTS1 and hevamine on polymeric chitin have been extensively studied, showing that these enzymes are endo-chitinases [3, 5, 7] . To allow future rapid evaluation of inhibitors, we decided to investigate the activity of ScCTS1 on 4-methylumbelliferyl chitooligosaccharides. Steady-state kinetics of ScCTS1 was established with 4MU-GlcNAc 3 , yielding a K m of 1 mM, with a k cat of 1.3 s À1 . While the turnover rate of the enzyme is comparable to the steady kinetics reported for hevamine on GlcNAc 5 , there exists a significant difference in the K m (K m of 16 mM, with a k cat of 0.6 s À1 for hevamine [5] ). This difference is likely to be due to the degree of polymerization of the substrate and the presence of the 4MU group instead of a GlcNAc unit in the +1 subsite. Activity against 4MU-GlcNAc 2 was also tested, and although turnover could be detected this was not sufficient to establish proper steady-state kinetics.
Recombinant ScCTS1 Has an Unusual pH Optimum
Using the 4MU-GlcNAc 3 substrate, the pH dependence of ScCTS1 in the pH range 2.2-7.0 was investigated. The enzyme shows a significant increase in activity toward the low pH range, with maximal k cat of 5.7 s À1 and k cat /K m of 0.0052 s À1 mM À1 at pH 2.6 ( Figure 3A ). The K m in the pH 2.2-5.0 range was between 1.0 and 1.4 mM, while at pH 6 and 7 the K m was 3.0 and 2.8 mM, respectively. This is similar to what has been described for native ScCTS1 partially purified from yeast extracts [7] and hevamine [5] . Such an unusual pH optimum has not been observed for the bacterial-type chitinases, which generally possess pH optima around pH 5-6 [6] , with one notable exception. The acid mammalian chitinase (AMCase), which falls within the bacterial-type chitinase subclass, also displays a pH optimum of around 2-3 [29] . Recent structural analysis of human AMCase has revealed that this shift in pH optimum is due to the mutation of a basic residue adjacent to a conserved aspartic acid positioned near the substrate in the À1 subsite of the active site (O.A. Andersen and D.M.F.v.A., unpublished data). Interestingly, in all plant-type family 18 chitinases this conserved aspartic acid is changed to a conserved asparagine (Asn215 in ScCTS1; Figure 2A ). Mutation of the aspartic acid to an alanine in the bacterial-type family 18 chitinase B from S. marcescens resulted in a significant downward shift of the pH optimum [30] . It is tempting to speculate that the asparagine at the equivalent position in the plant-type fungal chitinases is the source of the unusually low pH optimum.
ScCTS1 Is Inhibited by Allosamidin and Purine Derivatives
Allosamidin is a potent inhibitor of both bacterial-type and plant-type family 18 chitinases, and its mode of binding has been extensively characterized through enzymology and X-ray crystallography [13, 14, 23, 27, 31] . The hevamine-allosamidin complex has shown that the inhibitor mimics the oxazolinium intermediate through hydrogen bonds with the conserved Asp125 (Asp155 in ScCTS1) and Tyr183 (Tyr214 in ScCTS1) and extensive stacking with the conserved Trp255 (Trp285 in ScCTS1) [23] (Figure 4) . A modeled ScCTS1-allosamidin complex shows that the majority of the hydrogen bond interactions between the enzymes and the two sugars are conserved ( Figure 4A ). Given the conservation of these residues throughout the plant-type fungal chitinases, it is not surprising that allosamidin has been reported to inhibit partially purified ScCTS1 [20] . Similarly the ScCTS1 recombinant enzyme is competitively inhibited by allosamidin (K i = 0.61 ± 0.02 mM [ Table 2 ]; the K i against hevamine has been reported to be 3.1 mM [4]). Allosamidin is not an attractive starting point for the synthesis of potent planttype fungal chitinase inhibitors due to its inherent nondrug-likeness (hydrophilic cLogP [À5.2], high molecular weight, and presence of glycosidic bonds) and its complicated synthesis [32] . Recently, the more drug-like purine theophylline and derivatives thereof were identified as competitive bacterial-type family 18 chitinase inhibitors, displaying up to 3 mM inhibition and extensive mimicry of the allosamidin-chitinase interactions, as shown in Figure 4B [33, 34] . We investigated the inhibitory potential of these compounds against ScCTS1, revealing that the theophylline derivative 8-chlorotheophylline inhibits the enzyme with a K i of 600 ± 64 mM ( Table 2 ). This prompted us to investigate the binding mode of this compound. The crystal structure of ScCTS1 complexed with 8-chlorotheophylline was determined to 1.9 Å , with the final model of the complex giving an R factor of 0.198 (R free = 0.258).
The inhibitor shows extensive p-p stacking with Trp285 in the bottom of the À1 subsite, occupying the same position as observed in the AfChiB-theophylline complex (Figure 4) . Furthermore, the same hydrogen bonds are observed, from Tyr214 to the N9 nitrogen, from Asp155 to the N7 nitrogen, and from the backbone nitrogen of Ala110 to the O6 oxygen of the inhibitor. Notably, the 8-chloro atom points into the direction of the deep pocket that is observed in the native ScCTS1 structure ( Figure 2B )-this pocket is absent in the structure of bacterial-type chitinases such as AfChiB1 ( Figure 4B ). Strikingly, two water molecules are occupying this pocket in the ScCTS1-8-chlorotheophylline complex ( Figure 4B ). This suggests that inhibitors possessing moieties that could occupy this pocket and displace these water molecules would give additional favorable entropic contributions to binding. We next attempted to identify such inhibitors by a highthroughput screening campaign using a library of drug molecules.
Discovery of ScCTS1 Inhibitors Kinetin and Acetazolamide
A library of 880 drug-like molecules (The Prestwick Chemical Library) was screened at 40 mg/ml (approximately equivalent to 80 mM, assuming a molecular weight of 500) using 100 mM of 4MU-GlcNAc 3 . This led to the identification of two structurally distinct inhibitors, kinetin (a plant hormone) and acetazolamide (a well known carbonic anhydrase inhibitor) ( Figure 3B ). We next investigated the mode of inhibition of these compounds. Steady-state kinetics at different concentrations of 4MU-GlcNAc 3 in the presence of increasing amounts of the inhibitors showed that kinetin (K i = 3.2 mM; Figure 3C ) and acetazolamide (K i = 21 mM) were both competitive inhibitors. Next, the binding modes of these inhibitors were investigated by X-ray crystallographic analysis of their complexes with ScCTS1. The ScCTS1-acetazolamide complex was refined against 1.75 Å synchrotron data, yielding a final model with an R factor of 0.183 (R free = 0.232; Table 1 ). Despite containing a substantially different aromatic heterocycle, acetazolamide binds in a surprisingly similar mode as 8-chlorotheophylline ( Figures  4B and 5) . The stacking interaction with Trp285, and the hydrogen bonds with Tyr214, Asp155, and the backbone of Ala110 are conserved.
An additional hydrogen bond is observed between the catalytic acid (Glu157) and the acetamido nitrogen (Figure 5) . The sulfonamide group points toward the À2/À3 subsites, making weak interactions with the Trp285 indole nitrogen and an ordered water molecule. Notable, the deep pocket present in the ScCTS1 structure is still occupied by two ordered water molecules ( Figure 5 ).
The structure of the ScCTS1-kinetin complex was refined against 1.6 Å synchrotron data, yielding a final model with an R factor of 0.193 (R free = 0.222; Table 1 ). Although the purine substructure of kinetin binds in the same (Figures 4 and 5) . There is still extensive stacking between the purine moiety and Trp285, and hydrogen bonds to Tyr214 and Asp155 are also observed. The direct hydrogen bond to the backbone nitrogen of Ala110 observed in the 8-chlorotheophylline and acetazolamide complexes is a water-mediated hydrogen bond in the kinetin complex (Figures 4 and 5) . However, the main difference between the binding mode of kinetin and the other previously characterized inhibitors is that the kinetin furan group occupies the deep pocket, displacing the previously observed ordered water molecules in the 8-chlorotheophylline/acetazolamide complexes (Figures 4 and 5) . Furthermore, the furan group oxygen is also in a position suitable for stacking with the Tyr32 aromatic side chain. These extra interactions of the furfuryl group are likely to be the source of the tighter binding of the inhibitor, approaching the inhibition by allosamidin to within an order of magnitude.
A Key Amino Acid Regulates Plant-Type Fungal Chitinase Inhibitor Sensitivity
The deep pocket in the ScCTS1 chitinase ( Figures 2B, 4 , and 5) appears to be a key opportunity for increasing affinity both through displacement of ordered water molecules and establishment of further interactions. However, while the catalytic machinery of the plant-type fungal chitinases is fully conserved, analysis of sequence conservation around this pocket reveals two positions of sequence variation ( Figure 2 ). Amino acid 283 is an alanine, situated at the bottom of the ScCTS1 pocket (Figure 4 ). In hevamine, however, this residue is a much larger methionine (Met253; Figure 4A ). A methionine is also observed in A. nidulans chitinase A, whereas a serine is present at the equivalent position in all C. albicans plant-type chitinases ( Figure 2 ). It is thus worth establishing the effect of the presence of these larger side chains on the inhibitory potential of the inhibitors studied here. The ScCTS1 mutant A283S was made, emulating the pocket as present in the C. albicans plant-type chitinases. Steady-state kinetics of this mutant showed a similar K m (0.8 versus 1 mM for wild-type) and turnover number k cat (2.3 versus 1.3 for wild-type) as for the wild-type enzyme. Strikingly, while inhibition by allosamidin, acetazolamide, and 8-chlorotheophylline (Table 2 ) appeared to not be significantly affected by the larger serine present at position 283, inhibition by kinetin was no longer detectable. These data indicate that while in the C. albicans plant-type chitinases, which possess the large serine, a pocket may still exist, it is no longer able to accommodate large groups such as the kinetin furan side chain. It is likely that the methionines observed at this position for both the A. nidulans chitinase A and hevamine (Figure 2 ) would similarly abolish inhibition by kinetin. Indeed, the presence of this methionine in hevamine could be the source of the difference in allosamidin inhibition of ScCTS1 (K i = 0.61 mM) and hevamine (K i = 3.1 mM).
The second position of sequence variation in the pocket in ScCTS1 is Phe210, which is a tryptophan in hevamine and A. nidulans ChiA (Figure 2) . To probe the effect of this sequence variation on the structure of the pocket and binding of the inhibitors, the double mutant Phe210Trp/Ala283Ser was studied. Steady-state kinetics of this double mutant showed a similar K m (1.1 versus 1 mM for wild-type) and turnover number k cat (0.8 versus 1.3 for wild-type) as for the wild-type enzyme and the single Ala283Ser mutant. Again, while inhibition by allosamidin, acetazolamide, and 8-chlorotheophylline (Table 2) did not appear to be significantly affected by the larger Ser183 and Trp210, inhibition by kinetin was no longer detectable. These results indicate that sequence variation at position 283 appears to be a key determinant for binding affinities for inhibitors that occupy the deep pocket.
Concluding Remarks
Since the first report of the cell-clumping phenotype observed upon disruption of the cts1 gene [18] or inhibition of the ScCTS1 chitinase activity with allosamidin [20] , no complete knockout of all fungal plant-type chitinases in a single organism has been reported. Due to the large amount of redundancy in the fungal chitinase genes, the genetic approach toward knocking out all chitinase activity in a single fungal species is difficult to achieve. Because of this lack of genetic data, it is still difficult to ascertain the involvement of these plant-type fungal chitinases in virulence, morphogenesis, or growth. The work described here represents a first step toward the design and synthesis of a chemical tool to give significant inhibition of this subclass of family 18 chitinases. While the three scaffolds identified do not currently give submicromolar inhibition and the most potent of these, kinetin, appears sensitive to the identity of an unconserved amino acid, they are drug-like fragments that are synthetically accessible and could be further optimized using the structural data presented here.
SIGNIFICANCE
Chitinases are enzymes that catalyze the hydrolysis of the b(1,4)-glycosidic bonds between the N-acetyl-Dglucosamine (GlcNAc) monomers of chitin. Within the family 18 chitinases, two subfamilies exist, the extensively studied bacterial-type chitinases and the less well-studied plant-type chitinases with as prototype hevamine from Hevea brasiliensis. Both classes of enzymes are found in the genomes of yeast and fungi. Whereas the bacterial-type family 18 chitinases are nonessential, genetic data on the plant-type family 18 chitinases point to a role in cell wall morphology. For example, disruption of Aspergillus nidulans chiA leads to a defect in germination and hyphal growth, whereas the Saccharomyces cerevisiae chitinase 1 (ScCTS1) plays a key role in separation of mother and daughter cells at the end of cell division. Specific inhibitors of these enzymes would be useful as tools to study their role in cell wall morphogenesis and could possess antifungal properties. Here, we describe the crystallographic structure of a fungal plant-type family 18 chitinase, that of ScCTS1 and the results from a high-throughput screen against ScCTS1 using a library of currently marketed drugs, which could form the basis for development of inhibitors specific for this subclass of family 18 chitinases.
EXPERIMENTAL PROCEDURES
Materials
Oligonucleotides were supplied by the oligo synthesis service (School of Life Sciences, University of Dundee, UK). Restriction enzymes were obtained from New England Biolabs. Platinum high-fidelity Taq DNA polymerase, pCR2.1TOPO, pPICZaA, and X-33 strain were from Invitrogen. 4-methylumbelliferyl-b-D-N,N 0 ,N 00 -triacetyl-chitotrioside (4MU-GlcNAc 3 ) was from Sigma-Aldrich. HiTrapTM chelating HP column and glutathione sepharoseTM 4B were from Amersham Biosciences. All plasmids were verified by the sequencing service (School of Life Sciences, University of Dundee).
Cloning, Expression, and Purification
The cts1 gene from Saccharomyces cerevisiae was amplified using Platinum Taq DNA polymerase (Invitrogen), genomic DNA (AY925), and 5 0 and 3 0 end primers. The forward primer was 5 0 -TCTTCTGGT CTGGAAGTTCTGTTCCAAGGGCCACTGGATAGGTCTGCTAACAC AAATATTGCTG-3 0 , and the reverse primer was 5 0 -CCGCGGTCAT CAGGCGGTCTGGCTAGCACTTG-3 0 . In the forward primer, the sequence encoding a PreScission cleavage site is shown in bold, and in the reverse primer a SacII restriction site is shown in italics. The PCR product was purified and used as a template for PCR using the 5 0 end primer 5 0 CTCGAGAAAAGAGAGGCTGAAGCTCATCACCATC ACCATCACTCTTCTGGTCTGAAGTTCTGTTCCAAGGGCCACTG-3 0 .
In this primer, the sequence encoding a histidine tag is shown in bold, and a XhoI restriction site is shown in italics. The PCR product was ligated into a pCR2.1TOPO expression vector by the TOPO directional cloning procedure (Invitrogen). This vector was double digested with XhoI and SacII restriction enzymes, and the insert was ligated into pPICZaA. The plasmids were isolated from E. coli DH5a strain (pPICZaAsccts1). pPICZaAsccts1 was digested with SacI and transformed into X-33 strain with the LiCl method (Invitrogen HiTrap chelating HP column (5 ml) previously equilibrated with buffer A at a flow rate of 1 ml/min. The protein was washed with buffer A and eluted with buffer B (50 mM sodium phosphate, 300 mM sodium chloride, and 300 mM imidazole [pH 8]). After concentrating and dialyzing it against buffer C (50 mM HEPES, 250 mM sodium chloride, and 2 mM DTT [pH 7.5]), the protein was digested overnight with GSTPreScission protease at 4 C. The GST-PreScission protease was removed with glutathione sepharose 4B, and ScCTS1 was then applied onto a gel filtration column previously equilibrated with buffer C. Protein was concentrated and analyzed by SDS-PAGE followed by Coomassie blue staining. The purified ScCTS1 protein was used for kinetic analyses and crystallization trials. Construction of the ScCTS1 mutants was done by mutagenesis using the QuikChange Site-Directed Mutagenesis Kit, following the manufacturer's instructions. The mutant proteins were purified using the same procedures as used for the wild-type enzyme.
Enzymology
Michaelis-Menten parameters of ScCTS1 were determined using the fluorogenic substrate 4MU-GlcNAc 3 . Standard reaction mixtures contained 5 nM ScCTS1, 0.1 mg/ml BSA, and 25-800 mM fluorogenic substrate in McIlvaine's buffer (100 mM citric acid, 200 mM sodium phosphate [pH 5.5]) to a final volume of 50 ml. Reaction mixtures were incubated for 30 min at 37 C, after which the reaction was stopped with the addition of 25 ml of 3 M glycine-NaOH (pH 10.3). The fluorescence of the released 4-methylumbelliferone was quantified using an Flx 800 microtiterplate fluorescence reader (Bio-Tek Instruments Inc) (excitation 360 nm, emission 460 nm). The standard used was 4-methylumbelliferone at a concentration range covering those of the substrate used in the kinetic experiments. Experiments were performed in triplicate. Production of 4-methylumbelliferone was linear with time for the incubation period used, and less than 10% of available substrate was hydrolyzed. The pH study was carried out with a mix of citric acid and sodium phosphate (McIlvaine's buffer system, pH from 2.2 to 7), and the assay was done under the same conditions as described above. The backgrounds were determined with all the components of the assay and at each individual concentration of the substrate without the enzyme. The backgrounds ranged from 1,100 to 1,600 fluorescence units and were used to correct the values obtained when the enzyme was present (fluorescence units up to 45,000). The stability of the enzyme at different pHs and concentrations of substrates was also verified. The enzyme behaved with a very similar activity (from pH 2.2 to 5) during a time-course incubation (up to 25 hr), showing that the pH did not affect the stability of the enzyme. To check for linearity of the enzyme at different pH, a continuous assay was established (same conditions but without stopping the reaction) at pH 2.2, 2.6, 3.0, 4.0, 5.0, 6.0, and 7.0, and the reaction followed for up to 5 hr. From these experiments, appropriate reaction times were selected for the stopped, steady-state kinetics assays, such that the reactions did not consume more than 10% of available substrate. The same assay was used for screening The Prestwick Chemical Library (a library of 880 drug-like molecules obtained from Prestwick Chemical, Inc.). The inhibitors were screened at 40 mg/ml (approximately equivalent to 80 mM, assuming a molecular weight of 500) using a 4MU-GlcNAc 3 (substrate) concentration of 100 mM.
The IC 50 s of allosamidin, kinetin, acetazolamide, and 8-chlorotheophylline were determined using the same protocol but with a constant substrate concentration of 100 mM, 0.1-50 mM allosamidin, 1-500 mM kinetin or acetazolamide, and 0.1-6 mM 8-chlorotheophylline. In order to check for potential irreversibility or tight binding character of kinetin, a continuous assay was followed for 5 hr, revealing that the activity was linear in absence or presence of 50 or 100 mM kinetin. Lineweaver-Burk analyses of steady-state kinetics with 50-500 mM of substrate in the presence of different concentrations of kinetin/acetazolamide were used to show that these molecules were competitive inhibitors.
Crystallization and Structure Determination
The protein was spin-concentrated up to 11.5 mg/ml. Crystals were grown by sitting drop experiments at 20 C by mixing 1 ml of protein with an equal volume of a reservoir solution (0.1 M HEPES, 0.8 M monosodium di-hydrogen phosphate, and 0.8 M monopotassium dihydrogen phosphate [pH 7.5]). The crystals under these conditions appeared within 5-9 days. For flash cooling, 0.1 M HEPES and 30% glycerol (pH 7.5) was used for native crystals prior to data collection. For the ScCTS1-inhibitor complexes, native crystals were soaked with either 8-chlorotheophylline (30 mM), acetazolamide (30 mM), or kinetin (saturated solution) for more than 30 min. These crystals were soaked with 0.1 M HEPES, 40% PEG 600 (pH 7.5) for 10 s and flash cooled with liquid nitrogen for storage and transfer to the synchrotron. Data were collected at the European Synchrotron Radiation Facility (Grenoble, France). Diffraction data were processed with the HKL suite [35] (Table 1) .
The native ScCTS1 structure was solved by molecular replacement with MOLREP [36] using hevamine (PDB code 2HVM [3] ) as a search model, giving a single solution with one molecule in the asymmetric unit. The resulting electron density map was of very good quality, allowing ARP/WARP to automatically build 270 out of 294 residues of the polypeptide chain. Further refinement (with REFMAC5 [37] ) and model building (with COOT [38] ) yielded a model with the final statistics shown in Table 1 .
Refinement of ScCTS1 complexed with 8-chlorotheophylline, kinetin and acetazolamide was initiated by rigid-body refinement, followed by simulated annealing with CNS [39] (for 8-chlorotheophylline) and iterative cycles of refinement and model building. Models for ligands were not included until their conformations were completely defined by unbiased jF o j À jF c j, f calc electron density maps (Figures 4 and 5) . Ligand starting structures and topologies were generated with PRODRG [40] . Further refinement resulted in the final models described in Table 1 . WHAT IF [41] was used to calculate hydrogen bonds, and PyMol [42] was used to generate pictures.
